Home Page
Mail
Algeria Bahrain Cyprus Egypt Iran Iraq Jordan Kuwait Lebanon Libya Mauritania
Morocco Oman Palestine Qatar Saudi Arabia Sudan Syria Tunisia Turkey UAE Yemen


 
Thalassemia screening, charity drive and patriotic march mark National Day celebrations at Emirates Post
Montblanc displays unique pen with UAE flag to mark 37th national day
UAE partners international efforts to boost economic growth of developing nations: Al Mansouri
Leviton Showcases Industry Leading Cabling Solutions at Dubai DCD
Intercontinental hotels group (IHG) signs exclusive agreement to develop first resort in Oman’s coastal town of Duqum
Grand Final 9mm Pistol Shooting Competition 2008
 
qatar to become center of medical research in the middle east
Posted: 30-01-2008 , 11:53 GMT

qatar to become center of medical research in the middle east

SMARD corporation to develop treatments and diagnoses for diabetes and other chronic diseases in the Arab region


Today the Scientific Medical Applied Research & Development (SMARD) company announced its launch as Qatar’s first biotechnology and medical research company, becoming a member of Qatar Science & Technology Park (QSTP). SMARD will develop diagnostic tools and treatments for diseases, especially those that particularly affect Middle East and North Africa populations.
“SMARD will put Qatar on the international map of medical research and bring European expertise to our country," said Mr. Mohamed Al Hamed Al Marwani, Chairman and shareholder of SMARD. “An investment of several million dollars in the research and development will be aimed at treating chronic diseases, including diabetes and other long term diseases induced by disturbances of the immune system.”
SMARD is a subsidiary of the German companies KMG AG and iSIMA, which have close relations with universities in Tuebingen and others clinics and universities in Germany and Austria. It is expanding collaborations to universities in the Middle East with Cairo University and Menoufeya University in Egypt, as well as other international hospitals and R&D institutes.
“In Qatar, SMARD aims to work with the National Health Authority and Sidra Medical & Research Centre, and further the existing collaboration with Qatar University,” continued Mr. Al Marwani.
Professor Dr. Hans Werner Heinrich, a SMARD project leader, said:  “We have been working with universities and hospitals in Europe to find new ways of fighting inflammatory diseases. With Qatar’s investment in the Science & Technology Park, it is the perfect opportunity to further our research in the Middle East.”
Qatar Science & Technology Park is part of the Qatar Foundation, founded by H.H Sheikh Hamad Bin Khalifa Al-Thani, Emir of Qatar, and chaired by his wife H.H Sheikha Mozah Bint Nasser Al-Missned. QSTP’s purpose is to grow Qatar’s knowledge economy, by attracting companies and entrepreneurs from around the world to develop and commercialise their technology in Qatar.
Dr. Eulian Roberts, Managing Director of Qatar Science & Technology Park, added:  “Qatar has already made great strides in growing its knowledge economy in areas like energy, the environment and IT.  SMARD coming to the science park is important because it signifies our expansion into health sciences as well.  They are a cutting-edge biomedical company and we warmly welcome their partnership.”
 

© 2008 Al Bawaba (www.albawaba.com)

Printable Version
Top of Page
Printable Version
Opinions - No Opinions found for this article
 
 
 
 

  About Us Advertising Contact Us Privacy  
© 2008 Al Bawaba (www.albawaba.com)